Biotie Therapies Corp operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Biotie Therapies Corp with three other
miscellaneous service companies in Europe:
Oryzon Genomics Sa
sales of 4.25 million Euro [US$4.67 million]
of the United Kingdom
(£3.12 million [US$3.83 million]
based in Germany
(4.14 million Euro [US$4.54 million]
of which 100%
Sales fell dramatically in 2015:
During the year ended December of 2015, sales at
Biotie Therapies Corp were 3.74 million Euro (US$4.10 million).
decrease of 74.9%
versus 2014, when the company's sales were 14.90 million Euro.